NEPHROGENEX INC COM
NRX
NRX was delisted on the 10th of May, 2016.
14 hedge funds and large institutions have $31M invested in NEPHROGENEX INC COM in 2014 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
219% more capital invested
Capital invested by funds: $9.74M → $31M (+$21.3M)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 15 → 14 (-1)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$861K |
| 2 |
VAM
Visium Asset Management
New York
|
+$843K |
| 3 |
EWM
Edge Wealth Management
New York
|
+$2.31K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$926 |
| 5 |
Citigroup
New York
|
+$398 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$217K |
| 2 |
FNYS
First New York Securities
New York
|
-$108K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$104K |
| 4 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$90K |
| 5 |
FWCM
First Western Capital Management
Los Angeles,
California
|
-$61K |
NRX Hedge Fund Activity: Q4 2014 in Review
14 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q4 2014, worth a combined $31M — up 219% from $9.74M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NRX positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $861K. The largest seller was Knoll Capital Management, cutting an estimated $217K.
- 14 institutional investors held NEPHROGENEX INC COM (NRX) as of Q4 2014, down from 15 in Q3 2014.
- Funds reported $31M of NEPHROGENEX INC COM stock for Q4 2014, up 219% quarter-over-quarter.
- 4 funds opened new NEPHROGENEX INC COM positions in Q4 2014 and 3 closed out, a net change of +1 holder.
- The largest NEPHROGENEX INC COM buyer in Q4 2014 was Morgan Stanley, an estimated $861K added.
- The largest NEPHROGENEX INC COM seller in Q4 2014 was Knoll Capital Management, an estimated $217K sold.
Based on aggregated 13F filings for Q4 2014.